Furthermore, Dong et al. (2020) found different phenotypic cell surface markers (CK +/EpCAM-, CK-/EpCAM +, CK +/EPCAM +) in CTCs from prostate cancer patients isolated by two different methods that do not depend on cell surface expression markers [25]. This evidence concerns the gene EPCAM and prostate carcinoma.